1. Background {#sec4203}
=============

Hepatocellular carcinoma (HCC) is the most common primary hepatic tumor and the third leading cause of cancer-related deaths in humans, with nearly 600,000 deaths annually worldwide ([@A6192R1], [@A6192R2]). Epidemiological evidence has clearly demonstrated that chronic infection with the hepatitis B virus (HBV) is the major risk factor for developing HCC ([@A6192R3]), especially in southeastern Asia and Sub-Saharan Africa ([@A6192R3]-[@A6192R5]). Nonetheless, the mechanisms by which HBV contributes to the pathogenesis of HCC have not been fully elucidated. The Wnt signaling pathway is critical and highly conserved for proper embryonic development ([@A6192R6]). However, aberrant activation of the classic Wnt pathway has been shown to play an important role in the development of many types of human cancers ([@A6192R6]). A hallmark of Wnt pathway activation is the elevation of β-catenin in the cytoplasm and its further transport into the cell nucleus. Besides the canonical pathway, the Wnt signaling system also has alternative routes, generally known as the non-canonical pathway. These include Wnt-induced alterations in Ca2+ uptake and protein kinase C activation ([@A6192R7]). Mutations in components of the Wnt signaling pathway, such as the genes adenomatous polyposis coli (APC), β-catenin (CTNNB1), and the axins (AXIN1 and AXIN2), promote activation of the non-canonical pathway and thereby contribute to the initiation and promotion of carcinogenesis. Regarding HCC, Kondo et al.([@A6192R8]) reported that 18% to34% of patient samples had exon ([@A6192R3]) mutations in the CTNNB1 gene. In particular, the elevated expression of β-catenin was observed in 58.4% of HBV-associated HCCs and significantly correlated with large tumor size, poor histological grade, and high tumor grade, suggesting that the altered Wnt signaling pathway may play a crucial role in the pathogenesis of the HBV-associated HCC ([@A6192R9]).

2. Objectives {#sec4204}
=============

The present study characterized the differential expression profiles of 126 genes related to the Wnt pathway between primary tumor and adjacent normal tissues in patients with HBV-associated HCC. Our results could broaden our understanding of the role of the Wnt signaling pathway in HBV-associated HCC.

3. Materials and Methods {#sec4205}
========================

3.1. Patients and Specimens
---------------------------

Between January 2009 and September 2010, 56 primary HCC specimens and surrounding non-neoplastic tissues (taken 5 cm away from the tumor edge) were collected from patients who had been undergone curative surgery at the General Hospital of Jinan Military Command. 51 were men and 5 women, with a median age of 51 years (range: 23-76 years). Of these, 37 cases had serum alpha-fetoprotein (AFP) ≥ 30 µg/L, and 50 had positive findings for hepatitis B surface antigen (HBsAg).

None of these patients had positive findings of HCV infection or had undergone prior chemotherapy or radiotherapy. On gross examination, in 5 cases the tumor was \< 2 cm, whereas in 51 cases was \> 2 cm (mean, 5.1 cm; range, 1.0-13 cm). The clinic pathological findings were classified in accordance with the tumor-node-metastasis (TNM) staging system for malignant tumors of the World Health Organization and International Union against Cancer. All tumor tissues were diagnosed histopathologically by at least two trained pathologists. The resected tumors and matched non-cancerous tissue specimens used for microarray analysis and mRNA detection were immediately frozen in liquid nitrogen. The Ethics Committee of General Hospital of Jinan Military Command approved the study protocol. Informed written consent was obtained from each patient before the operation.

3.2. RNA Extraction and Processing for Microarray Analysis
----------------------------------------------------------

Microarray analysis was performed, as described previously ([@A6192R10]) using RNA isolated from tumor tissues and matched non-neoplastic tissues derived from 10 HCC patients, with some modifications. The clinical characteristics of these patients are listed in [Table 1](#tbl1437){ref-type="table"}. In brief, total RNA was isolated from tissues using Trizol reagent (Invitrogen, Carlsbad, CA, USA) in accordance with the manufacturer's suggested protocol ([@A6192R11]) and then quantified with a spectrophotometer. Using the True-Labeling AMPTM Linear RNA amplification kit (Super Array Bioscience, Qiagen), the mRNA was reverse-transcribed into cDNA and converted into biotin-labeled cRNA using biotin-16-UTP via in vitro transcription. The purified cRNA probes were then hybridized to the pretreated OligoGEArray® Human Wnt Signaling Pathway arrays (Cat. No. OHS-043; Super Array Bioscience) containing 126 Wnt-related genes. After washing steps, array spots binding cRNA were detected using the chemiluminescence method (manufacturer's protocol). The differentially expressed genes between HCC tissues and adjacent normal tissues were filtered based on fold-change cutoffs of ≤ 0.5 and ≥ 2 for down regulated and up regulated genes, respectively.

###### Clinical Features of the Ten Patients With HBV-Associated HCC

  Patient No.   Gender   Ages   TNM stage   HBsAg      Cirrhosis
  ------------- -------- ------ ----------- ---------- -----------
  **1**         Male     68     T4          Positive   Yes
  **2**         Male     37     T4          Positive   Yes
  **3**         Male     41     T3          Positive   Yes
  **4**         Male     57     T3          Positive   Yes
  **5**         Male     32     T3          Positive   Yes
  **6**         Female   63     T2          Positive   Yes
  **7**         Male     73     T2          Positive   Yes
  **8**         Male     58     T3          Positive   Yes
  **9**         Male     57     T3          Positive   Yes
  **10**        Male     49     T2          Positive   Yes

Abbreviations: HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HBsAg, hepatitis B surface antigen.

3.3. Quantitative Real-Time RT-PCR
----------------------------------

Quantitative real-time RT-PCR (qRT-PCR) was performed as described previously ([@A6192R12]). Reverse transcription was performed on 1 μg of total RNA from each sample using the MMLV Reverse Transcriptase 1st-Strand cDNA Synthesis Kit (Illumina), by following the manufacturer's instructions. qRT-PCR was performed using SYBR Green in a Rotor-gene 3000 thermal cycler (Corbett Research, Sydney, Australia).

The PCR primer sequences were designed for the selected genes and β-actin based on the gene sequences reported in GenBank and were chemically synthesized ([Table 2](#tbl1438){ref-type="table"}). The specificity of the PCR was confirmed by examining the dissociation reaction plot subsequent to qRT-PCR. β-actin served as the constitutive control. PCR of each sample was conducted in triplicate. Data was analyzed using the comparative cycle threshold (Ct) method.

###### Primer Sequences Usedfor qRT-PCR

  Primer            Sequences                    Annealing Temperature, °C   Product Size ,bp
  ----------------- ---------------------------- --------------------------- ------------------
  **FZD2-F**        5'-CATCGTCATCGCTTGCTACT-3'   58                          252
  **FZD2-R**        5'-CTGTTGGTGAGGCGAGTGTA-3'                               
  **DVL3-F**        5'-AGGTGCCTATGCAAGTTCA-3'    58                          138
  **DVL3-R**        5'-TGTGCGAGGTTTAAGGTCTA-3'                               
  **PYGO2-F**       5'-GCTGCTAACGATGGGTGAC-3'    58                          116
  **PYGO2-R**       5'-AAGCCAGTGGAAACAAGGAC-3'                               
  ***β-actin-F***   5'-CCTGTACGCCAACACAGTGC-3'   58                          211
  ***β-actin-R***   5'-ATACTCCTGCTTGCTGATCC-3'                               

Abbreviations: FZD2, Frizzled homolog 2; DVL3, disheveled 3; PYGO2, Pygopus homolog 2.

3.4. Immunohistochemistry (IHC)
-------------------------------

Fifty-six HCC tissues were fixed in formalin, embedded in paraffin, and cut into 4 μm-thick sections. Sections were pretreated, dewaxed in xylene, and hydrated before antigen retrieval. After endogenous peroxidase inhibition, sections were incubated with a polyclonal antibody against human DVL3 (1:100; ab76081, Abcam, Hong Kong) overnight at 4 °C. After thorough washing with phosphate-buffered saline (PBS), corresponding secondary antibodies were applied and incubated at room temperature for 30 min ([@A6192R13]). Reaction products were visualized by incubation with 3,3'-diaminobenzidine (DAB) and then counterstained with hematoxylin. Negative controls were achieved by substituting the primary antibody with isotype-matched irrelevant antibody.

3.5. Evaluation of Immunostaining
---------------------------------

DVL3 staining was judged by two pathologists (Geng M and Cao YC) who were blinded to theclinical details related to the patients. Immunostaining was expressed as the percentage of stained cells to the total number of cells, and assigned to one of the four categories: 0, 0%; 1, 0% to 10%; 2, 10% to 50%; and 3, \> 50%. The intensity of immunostaining was graded on a semi-quantitative scale (0-3): 0, negative; 1, weakly positive; 2, moderately positive; and 3, strongly positive. The two scores were multiplied and the product was defined as the IHC score. Final IHC scores below 4 indicated a low-level DVL3 expression; while more than 5was considered as high-level.

3.6. Statistical Analysis
-------------------------

Pearson\'s correlation analysis was performed to compare microarray and qRT-PCR data. The chi-squared test was used to analyze the relationship between DVL3 expression and clinic pathological characteristics. All statistical analyses were performed with SPSS version 11.0 software (SPSS, Chicago, IL, USA). A P value below 0.05 was considered statistically significant.

4. Results {#sec4206}
==========

4.1. Differential Wnt Pathway Gene Expression Between HCC and Adjacent Normal Tissues
-------------------------------------------------------------------------------------

We used OligoGEArray® Human Wnt Signaling Pathway arrays comprises 126 probe sets designed to measure human Wnt-related mRNAs to compare the gene expression profiles of primary HCC tumor and matched non-neoplastic tissues. We identified sixteen genes (12.7%, 16/126) which differed in expression significantly in at least six paired tissues. Of these, seven genes were up regulated ([Table 3](#tbl1439){ref-type="table"}) and nine genes were down regulated ([Table 4](#tbl1440){ref-type="table"}) in HCC tissues compared to the adjacent normal specimens. Remarkably, frizzled homolog 2 (FZD2) was overexpressed in nine of the HCC tissues, and pygopus homolog 2 (PYGO2) and split-hand/split-foot malformation 3 (SHFM3) were both downregulated in nine HCC tissues compared to their matched normal tissues. These differentially expressed genes are specifically related to the Frizzled signaling pathway, cell cycle, transcription, or protein degradation.

###### Seven UpRegulated Genes (\> 2-Fold Increase) in HCC Tissues Compared to the Matched Normal Tissues

  Gene                                                       Genbank ID   Symbol   Description
  ---------------------------------------------------------- ------------ -------- --------------------------------------------------------------------------------
  **Frizzled 2**                                             NM_001466    FZD2     G-protein coupled receptor which binds to Wnt proteins
  **Casein kinase I isoform delta**                          NM_001893    CSNK1D   Serine/threonine protein kinases
  **Disheveled, dsh homolog 3**                              NM_004423    DVL3     Protect β-catenin from *phosphorylated by kinase*
  ***Ras*****homolog gene family, member U**                 NM_021205    RHOU     *Ras* homolog gene family, member U
  **Secreted frizzled-related protein 4**                    NM_003014    SFRP4    A member of the SFRP family which acts as soluble modulators of Wnt signaling.
  **WNT1-inducible signaling pathway protein-1**             NM_003882    WISP1    Involved in cell growth
  **Wingless-type MMTV Integration site family, member 3**   NM_030753    WNT3     A member of the Wnt *gene* family of secreted proteins

Abbreviation: HCC, hepatocellular carcinoma.

###### Information for the Nine Down-Regulated Genes (\< 2-Fold Increase) in HCC Tissues Compared to Their Matched Tissues

  Gene                                                          Genbank ID   Symbol   Description
  ------------------------------------------------------------- ------------ -------- --------------------------------------------------------
  **Pygopus 2**                                                 NM_138300    PYGO2    Transcription factor
  **Split-hand/split-foot malformation 3**                      NM_022039    SHFM3    Involved in the ubiquitin pathway
  **Adenomatous polyposis coil 2**                              NM_005883    APC2     Tumor suppressor
  **Fos-like antigen 1**                                        NM_005438    FOSL1    Transcription factor
  **Naked cuticle 1 homolog (*Drosophila*)**                    NM_033119    NKD1     A component of Wnt signaling pathway, unknown function
  **Naked cuticle 2 homolog (*Drosophila*)**                    NM_033120    NKD2     A component of Wnt signaling pathway, unknown function
  **Protein phosphatase 2, catalytic subunit, alpha isozyme**   NM_002715    PPP2CA   Involved in cell cycle and apoptosis
  **Transducin-like enhancer of split 4**                       NM_007005    TLE4     A component of Wnt signaling pathway
  **Wingless-Type MMTV Integration Site Family, Member 10A**    NM_025216    WNT10A   A member of Wnt signaling pathway

Abbreviation: HCC, hepatocellular carcinoma.

4.2. Validation of the Data From the Microarray by qRT-PCR
----------------------------------------------------------

To validate the differentially expressed genes identified through expression microarray analysis, we performed qRT-PCR for FZD2, PYGO2, and DVL3, which had been found differentially expressed in at least six HCC tissues. There was a strong association between the two methods for all three of the genes which were compared, as revealed by the P values and Pearson's correlation coefficients (FZD2, 0.987; DVL3, 0.920; PYGO2, 0.947; P\< 0.001 for all). Compared to the adjacent normal tissues, the mRNA expressions of DVL3 and FZD2 were up regulated, whereas PYGO2 mRNA was down regulated in the HCC tissues (All P\< 0.05).

4.3. DVL3 Protein Expression in HCC
-----------------------------------

To determine whether the up regulation of DVL3 protein is linked to the clinical variables of HCC patients, we examined the expression of DVL3 protein in 56 HCC tissue samples with IHC. Positive staining which indicated the presence of DVL3 protein was mainly localized to the cytoplasm of tumor cells ([Figure 1](#fig1377){ref-type="fig"}). Using DVL3 immunoreactive intensity as the determinant, 25 (44.6%) patients were classified as low-DVL3 and 31 (55.4%) as high-DVL3. In addition, there was a significant positive correlation between the levels of DVL3 mRNA and DVL3 protein in the primary tumor tissues and the matched adjacent normal tissues (P = 0.031). [Table 5](#tbl1441){ref-type="table"} summarizes the association between DVL3 expression and the clinic pathological variables of the HCC patients. The expression of DVL3 protein was significantly correlated with the patients\` tumor stage (P = 0.025). However, statistical analyses failed to reveal any significant correlations between DVL3 expression and other clinic pathological factors.

###### The Relationship Between DVL3 Expression and Clinic pathological Features in Hepatocellular Carcinomas

                              No.   DVL3 Immunoreactivity   *P*value   
  --------------------------- ----- ----------------------- ---------- -------
  **Gender**                                                           NS
  Male                        51    28                      23         
  Female                      5     3                       2          
  **Age, y**                                                           NS
  \< 51                       21    12                      9          
  ≥ 51                        35    19                      16         
  **Serum AFP level, µg/L**                                            NS
  \< 30                       19    11                      8          
  ≥ 30                        37    20                      17         
  **HBsAg**                                                            NS
  Positive                    50    27                      23         
  Negative                    6     4                       2          
  **Tumor size**                                                       NS
  ≤ 2 cm                      5     3                       2          
  \> 2 cm                     51    28                      23         
  **Histological grade**                                               NS
  Well differentiated         8     5                       3          
  Moderately differentiated   30    18                      12         
  Poorly differentiated       18    8                       10         
  **Liver cirrhosis**                                                  NS
  Absent                      16    9                       7          
  Present                     40    22                      18         
  **T classification**                                                 0.025
  T1                          2     0                       2          
  T2                          27    11                      16         
  T3                          15    10                      5          
  T4                          12    10                      2          
  Total                       56    31                      25         

Abbreviation: NS, not significant.

![IHC Detection of DVL3 Protein Expression in HCC Tissue Samples\
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5. Discussion {#sec4207}
=============

The Wnt signaling pathway is essential to a variety of biological processes. Dysregulation of this pathway is a common hallmark of many human cancers, including HCC ([@A6192R14], [@A6192R15]). The data reported here clearly demonstrate that a group of genes directly or indirectly related to the Wnt pathway are dysregulated in HCC. The expression of FZD2 was up regulated in HCC tissues compared to the matched non-neoplastic tissues. FZD2, a member of Frizzled receptor family, contains a seven-transmembrane domain that serves as binding sites for many Wnt proteins ([@A6192R16]). Casein kinase 1Δ (CSNK1D) is a member of the casein kinase I family (CKI), and CKI phosphorylates APC, axin, and β-catenin. CKI phosphorylates β-catenin at serine 45, and thereby allows progressive phosphorylation with glycogen synthase kinase 3β (GSK3B) and ubiquitination([@A6192R17]). We detected upregulation of DVL3 in HCC tissues. DVL3 inhibits the activity of GSK3B directly and protects β-catenin from degradation, therefore contributes to abnormal cell proliferation ([@A6192R18]). WISP1 (WNT1-inducible-signaling pathway protein 1), a downstream regulator in the Wnt pathway, and the well-known oncogenes RHOU and WNT3 were also up regulated in HCC tissues. Previous evidence clearly showed that the expression of SFRP4 (secreted frizzled-related protein 4) was up regulated in colorectal cancer tissues, but down regulated in other cancer types ([@A6192R19]); we found it to be upregulated in HCC tissues. This suggests that SFRP4 has a cell-specific function in different tumors. We also found nine genes which are down regulated in HCC tissues compared to matched normal tissues. Of these, NKD1 (naked cuticle 1), NKD2 and TLE4 (transducin-like enhancer protein) participate in the Wnt signaling pathway, through mechanisms which are not completely understood. APC2, a well-known tumor suppressor gene, is down regulated in many tumors ([@A6192R20]). We consistently observed that APC2 was also down regulated in our examined HCC tissues. The present study also indicated that the SHFM3 gene, which is involved in the ubiquitin pathway, was down regulated in HCC tissues, suggesting aberrant activation of the classic Wnt pathway. However, we found down regulation of PYGO2, which was founded to be up regulated in ovarian cancer ([@A6192R21]). Moreover, FOSL1 (fos-related antigen 1), a downstream regulator in the Wnt pathway, was overexpressed significantly in HCC tissues. Understanding the exact roles of these genes in HCC requires further elucidation. In the present study, we performed qRT-PCR analysis of FZD2, PYGO2, and DVL3 to validate the microarray data. Moreover, we assessed the DVL3 protein expression in 56 HCC tissues with IHC. High-level of DVL3 expression was observed in 55.4% (31 of 56 cases) and correlated with tumor stage (P = 0.029). Collectively, our findings suggest that the DVL3 is up regulated in HCC tissues and positively participates in HCC progression. Nonetheless, further studies are needed to elucidate the molecular mechanisms by which the DVL3 participates in the development and progression of HCC, and to address whether the DVL3 could be used as a target for novel therapeutic approaches. In summary, the present microarray study revealed that a number of Wnt pathway genes are dysregulated in HBV-associated HCC, which may be contributed to the frequent activation of the Wnt signaling pathway. Our results may reveal further understanding of the role of the Wnt signaling pathway in HBV-associated HCC.
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**Implication for health policy/practice/research/medical education:** This study clarified a number of Wnt pathway-related genes which are dysregulated in HBV-associated HCC. These genes may be contributed to the frequent activation of the Wnt signaling pathway. Our results promote the role of the Wnt signaling pathway in HBV-associated HCC. The "HCC", "DNA microarray", "HBV" and "Wnt pathway" audiences should all find some interests in the work, for which we brought together diverse techniques and areas of expertise.
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